Role of omega-3 in preventing cognitive decline in older people questioned
Older people who take omega-3 fish oil supplements are probably not reducing their chances of losing cognitive function, according to a new Cochrane systematic review by researchers at the London School of Hygiene & Tropical Medicine.
Based on the available data from studies lasting up to three-and-half years, the researchers concluded that the supplements offered no benefits for cognitive health over placebo capsules or margarines, but that longer term effects are worth investigating.
Omega-3 fatty acids are fats responsible for many important jobs in the body. We get these fats through our daily diets and the three major omega-3 fats are: alpha linolenic acid (ALA) from sources such as nuts and seeds and eicosapentoic acid (EPA) and docosahexaenoic acid (DHA) from sources including oily fish such as salmon and mackerel. A number of studies have hinted that omega-3 fatty acids and DHA in particular may be involved in keeping nerve cells in the brain healthy into old age. However, there is limited evidence for the role of these fats in preventing cognitive decline and dementia.
The researchers, led by Emma Sydenham, gathered together evidence from three high quality trials comparing the effects of omega-3 fatty acids taken in capsules or margarine spread to those of sunflower oil, olive oil or regular margarine. A total of 3,536 people over the age of 60 took part in the trials, which lasted between six and 40 months. None of the participants had any signs of poor cognitive health or dementia at the start of the trials. The researchers found no benefit of taking the omega-3 capsules or spread over placebo capsules or spread. Participants given omega-3 did not score better in standard mental state examinations or in memory and verbal fluency tests than those given placebo.
Alan Dangour, a nutritionist at LSHTM and co-author of the report, said: “From these studies, there doesn’t appear to be any benefit for cognitive health for older people of taking omega-3 supplements. However, these were relatively short-term studies, so we saw very little deterioration in cognitive function in either the intervention groups or the control groups. It may take much longer to see any effect of these supplements.”
The researchers conclude that the longer term effects of omega-3 fatty acids on cognitive decline and dementia need to be explored in further studies, particularly in people with low intakes of omega-3 fatty acids in their diet. In the meantime, they stress other potential health benefits. “Fish is an important part of a healthy diet and we would still support the recommendation to eat two portions a week, including one portion of oily fish,” said Dr Dangour.
Emma Sydenham had a special personal motivation for conducting the research. When she started the project her 101-year-old grandmother Dorothy Sydenham had dementia and was being cared for by her family. Mrs Sydenham, a nurse who lived in London through the First and Second World Wars, died in 2010 – a week before her 102nd birthday.
For more information or to request interviews please contact the LSHTM press office on +44 (0)20 7927 2802 or email email@example.com
Notes to Editors:
1. Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database of Systematic Reviews 2012, Issue 6. Art. No.: CD005379. DOI: 10.1002/14651858.CD005379.pub3
2. The Cochrane Library contains high quality health care information, including the Cochrane Database of Systematic Reviews, from the Cochrane Collaboration. Cochrane Systematic Reviews bring together research on the effects of health care and are considered the gold standard for determining the relative effectiveness of different interventions. The Cochrane Collaboration (http://www.cochrane.org) is a UK registered international charity and the world's leading producer of systematic reviews.
3. Image: MRI head scan, side view. Credit: iStockphoto.com/CGinspiration